Patient and Physician Perspectives Inform Clinical Trial Design for a Single Intravenous Dose of HMI-203, a Gene Therapy Candidate for Adults with Mucopolysaccharidosis Type II (MPS II, Hunter Syndrome)
Molecular genetics and metabolism（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要